Effectiveness of two tobacco cessation methods among TB patients

Int J Tuberc Lung Dis. 2022 Jan 1;26(1):12-17. doi: 10.5588/ijtld.21.0211.

Abstract

BACKGROUND: Tobacco and TB are the world´s two greatest public health problems. Exposure to tobacco has been shown to be associated with higher risk of acquiring TB and adverse outcomes such as relapse and TB mortality.OBJECTIVE: To assess and compare self-reported tobacco quit status and biochemically verified cotinine levels among TB patients at different time intervals among two study groups.METHODS: A cluster, randomised controlled trial was conducted on TB patients attending DOTS centres in Delhi, India, who reported using tobacco in any form. Participants were assigned into one of two treatment groups. Centres were randomly assigned to two intervention groups: 1) integrated intervention using behavioural counselling with nicotine replacement therapy (NRT) gum, and 2) intervention using behavioural counselling alone (50 each in intervention and control group). The subjects were followed at Week 1, Month 1, Month 3 and Month 6 for tobacco cessation.RESULTS: At the end of 6 months, patients who received the integrated intervention had significantly higher rate of success in quitting tobacco than those who received the conventional TB treatment alone (78.7% vs. 57.8%; P < 0.03).CONCLUSION: DOTS with tobacco use dependence treatment was successful in our study in helping TB patients to quit tobacco dependence and should therefore be offered to every tobacco user.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Cotinine
  • Humans
  • Smoking Cessation* / methods
  • Tobacco Use Cessation Devices
  • Tobacco Use Cessation*
  • Tobacco Use Disorder* / complications
  • Tobacco Use Disorder* / therapy
  • Tuberculosis

Substances

  • Cotinine